http://www.ybe.com.tw/contact.html明達實業股份有限公司http://www.ybe.com.tw/images/corpimg.png23450 新北市永和區福和路389號9樓$02-2928-1900明達實業股份有限公司為醫療保健公司，設立於1986年，致力於保健、疾病治療與造福人群。 我們的目標在於引進先進的高科技醫療產品，來改善、治療患者的疾病，使患者病痛得以緩解或痊癒，進而增進患者的健康和生活品質。我們的責任是提供多樣化的高品質產品給需要的病患，特別是腫瘤的分子檢測和用藥，我們具備了多年的專業經驗，已讓廣大的病患得到最大的幫助。為了 明達實業股份有限公司 更寬廣的未來，我們將以專業服務延伸企業目標，並加以實踐"明查病因，藥達病癒"的公司願景，期許將明達之醫療事業帶到社會之各個角落。 Yeong Being Enterprises Co., Ltd. (YBE) was founded in 1986, managing distribution pharmaceutical products in Taiwan, and also doing export business to Korea and other Asia countries.YBE has been marketing oncology products and orphan drugs in Taiwan over ten years, distribute the products of Chiron Corporation, namely Proleukin® (aldesleukin), Tobi® (Tobramycin solution for inhalation)and Cardioxane® (Dexrazoxane hydrochloride)since 1999. Now YBE is working with Novartis after Chiron was acquired by Novartis in 2005, selling Proleukin product very well every year, even that Metastatic renal cell carcinoma and malignant melanoma are rare cancers in Asians. YB is also contracted as BTG distributor in Taiwan for selling unique products as DigiFab® (digoxin immune Fab (ovine)) and Voraxaze®(glucarpidase). Hence, YBE is very experienced and gain good connections with the medical professionals in drug and medical device fields, also co operate with SSPL in France for female contraceptive sponge which we have contracted selling and manufacturing in Taiwan. As the economy and health expenditure is expanding rapidly, YBE foresees there is much room for the growth of pharmaceutical products in Taiwan for the coming years. In 2012, YBE provides a new service for breast cancer patients is Symphony Breast Cancer Suite (Personalized Breast Cancer Genomic Profile), which is an advanced genomics platform for tumor gene expression profiling and built microarray assay tests that can determine whether an individual patient is at high or low risk for breast cancers recurrence, helping physicians more accurately tailor cancer treatments.
